2) sustained-release microsphere
缓释微球
1.
Preparation and evaluation of sustained-release microsphere of Sanguis Draconis in vitro;
血竭聚乳酸缓释微球的制备及体外释药研究
2.
Preparation and in vitro release of sustained-release microspheres of loxoprofen sodium
洛索洛芬钠缓释微球的制备及体外释药特性考察
3.
Objective: A sustained-release microsphere was prepared by using Silk Fibroin(SF) and Chitosan(CS)as carriers and Diclofenac Sodium(DS) as model medicine,based on porous structure of SF and excellent plasticity of CS.
目的:本文利用丝素蛋白特殊孔性结构以及壳聚糖优良成型性的特性,选用非甾体抗炎药双氯芬酸钠(Diclofenac Sodium ,DS)作为模型药物,以丝素蛋白(Silk Fibroin ,SF)和天然材料壳聚糖(Chitosan ,CS)制备双氯芬酸钠丝素蛋白/壳聚糖缓释微球(DS-SF/CS -MS),通过两者之间的键合作用形成复合体,利用微球溶胀特性,增强药物在体内的作用时间,减少DS对胃肠道的刺激,降低毒副作用,延长作用时间,提高其顺应性。
3) sustained release microspheres
缓释微球
1.
A novel spherical crystallization technique method was used to prepare sustained release microspheres of ibuprofen with acrylic polymer.
采用一种新型的缓释微球制备方法——液体球形结聚技术 ,制备布洛芬 -丙烯酸缓释微球 ,并对其处方工艺进行了筛选。
4) Sustained-release microspheres
缓释微球
1.
Preparation and characteristics of glucocorticoid sustained-release microspheres;
糖皮质激素缓释微球的制备与性质
2.
Preparation of oral insulin sustained-release microspheres;
口服胰岛素缓释微球的制备
3.
Preparation and in vitro release of goserelin acetate sustained-release microspheres
醋酸戈舍瑞林缓释微球的制备及体外释药研究
5) Microspheres
缓释微球
1.
In Vitro Release Experiment of Huperzine A Sustained-release Microspheres and Its Correlation Evaluation between In Vivo and In Vitro;
石杉碱甲缓释微球的体外释放度及其体内外相关性研究
2.
The Study on Sustained Release of EGF-loaded Microspheres and Its Repair Effect on Diabetic Ulcer;
表皮生长因子缓释微球对糖尿病皮肤溃疡创面修复作用的研究
6) microsphere
['maikrəsfiə]
缓释微球
1.
Test for in vitro release rate of microspheres and correlation of its in vivo-in vitro;
缓释微球的释放度试验及体内外相关性研究进展
补充资料：可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前，把二者注入靶动脉，可暂时减少动脉血流，再行化疗药物灌注，以减少血液冲刷，保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同，DSM和BAM仅造成数十分钟的血流量减少，待其被降解后血流可恢复至以前水平。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条